PHARYNDOL : Treatment for throat infection (pharyngitis)

Overview

Vitrobio presents PHARYNDOL, a specialized solution designed for the treatment of viral or bacterial throat infections, also known as pharyngitis. This product is a throat spray in a convenient 30 ml format, designed for easy application and optimal delivery of the active components.

Targeted Proteins and Actions

Protective Barrier Effect: PHARYNDOL works by creating a filmogenic liquid bandage on the throat mucous membrane. This protective barrier shields the throat from incoming contaminants and pro-inflammatory proteins. It also hydrates and soothes the irritated throat, providing immediate relief.

Mechanical Cleaning: The spray also exerts a high osmotic action, which instantly attracts and traps most of the adhered contaminants, including inflammatory proteins and other impurities. This mechanical cleaning suppresses inflammation and halts the immune cascade, leading to a reduction in throat infection symptoms.

Cellular Repair and Growth Effect: With the throat now in a clean and protected state, the healing process can effectively begin. The spray promotes cell growth and repair, allowing the throat mucosa to regenerate and regain its integrity. This restoration of the throat mucosa is crucial for long-term relief from pharyngitis.

Clinical Trial Results

The effectiveness of PHARYNDOL has been evaluated in a randomized, double-blind, placebo-controlled trial conducted over 2 weeks with 60 patients. The trial included individuals experiencing viral or bacterial throat infections.

The main results of the trial were highly promising:

• Significant reduction in throat pain and irritation within 2 hours, lasting throughout the treatment.
• Significant reduction in bacterial count within 2 hours, with an 81% reduction within 4 days and normal values within 7 days.
• Significant reduction in throat redness and inflammation within 2 hours, lasting throughout the treatment.
• Complete recovery within 2 days for 31% of patients, within 7 days for 61% of patients, within 10 days for 95% of patients, and within 14 days for 98% of patients.
• Requirements for antibiotics were strongly diminished in the test group compared to the placebo group.

Importantly, no side effects were recorded during the trial, demonstrating the safety of PHARYNDOL.

See full publication (PDF)

Main results

PAIN
Significant reduction in throat pain within 2 hours and throughout the treatment

BACTERIAL COUNT
3 % reduction in bacterial count within 2 hours.
62 % reduction in bacterial count within 1 day.
81 % reduction in bacterial count within 4 days.
Normal value within 7 days.

IRRITATION
Significant reduction in throat irritation within 2 hours and up to the day 7

REDNESS
Significant reduction in thoat redness/inflamation within 2 hours and throughout the treatment.

RECOVERY
Complet recovery within 2 days for 31 % of patients.
Complet recovery within 7 days for 61 % of patients.
Complet recovery within 10 days for 95 % of patients.
Complet recovery within 14 days for 98 % of patients.

ANTIBIOTICS
Requirements for antibiotics strongly diminished in the test group vs placebo group.​